Joinn Laboratories (China) Co.,Ltd. Stock OTC Markets
Stocks
JNNL.Y
US47972L1089
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 34.43B 5.1B 4.41B 4.12B 3.78B 7.11B 486B 7.22B 48.35B 18.98B 243B 19.16B 18.74B 805B | P/E 2026 * |
80.1x | P/E 2027 * | 79.8x |
|---|---|---|---|---|---|
| Enterprise Value | 32.54B 4.82B 4.17B 3.9B 3.57B 6.72B 459B 6.83B 45.7B 17.94B 230B 18.11B 17.71B 761B | EV / Sales 2026 * |
17.6x | EV / Sales 2027 * | 15.3x |
| Free-Float |
64.87% | Yield 2026 * |
0.19% | Yield 2027 * | 0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 44 | 28/01/2019 |
Ai Shui Yu
DFI | Director of Finance/CFO | 50 | 10/04/2020 |
Jing Liang Gu
PRN | Corporate Officer/Principal | 46 | 23/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Yu Xia Feng
CHM | Chairman | 62 | 11/08/1995 |
Da Peng Gao
BRD | Director/Board Member | 44 | 10/12/2012 |
Ye Li
CHM | Chairman | 44 | 10/12/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 5.1B | |
| +0.99% | +1.78% | +4.07% | +16.73% | 49.47B | |
| +3.71% | +9.40% | +486.98% | +592.14% | 43.61B | |
| +5.60% | +10.21% | +16.76% | +85.72% | 39.6B | |
| +2.70% | +1.57% | +33.39% | +8.85% | 39.29B | |
| +2.21% | +6.75% | +21.31% | +53.37% | 32.43B | |
| +2.23% | +4.71% | - | - | 16.84B | |
| +0.97% | +2.35% | +37.75% | +126.84% | 16.49B | |
| -0.11% | +2.41% | +6.24% | +18.87% | 14.01B | |
| +0.75% | +15.04% | +78.59% | +30.30% | 12.77B | |
| Average | +1.90% | +6.32% | +85.64% | +116.60% | 29.39B | |
| Weighted average by Cap. | +2.49% | +6.10% | +104.25% | +140.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 274M 237M 221M 203M 382M 26.06B 388M 2.59B 1.02B 13.06B 1.03B 1.01B 43.18B | 2.11B 313M 271M 253M 232M 436M 29.8B 443M 2.97B 1.16B 14.94B 1.18B 1.15B 49.37B |
| Net income | 492M 72.88M 63.04M 58.87M 54.01M 102M 6.94B 103M 691M 271M 3.48B 274M 268M 11.49B | 381M 56.44M 48.82M 45.59M 41.83M 78.67M 5.37B 79.92M 535M 210M 2.69B 212M 207M 8.9B |
| Net Debt | -1.89B -279M -242M -226M -207M -389M -26.59B -396M -2.65B -1.04B -13.33B -1.05B -1.03B -44.06B | -2.12B -314M -272M -254M -233M -438M -29.93B -445M -2.98B -1.17B -15B -1.18B -1.15B -49.59B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
